197 related articles for article (PubMed ID: 25220739)
1. Early discontinuation of attention-deficit/hyperactivity disorder drug treatment: a Danish nationwide drug utilization study.
Pottegård A; Bjerregaard BK; Kortegaard LS; Zoëga H
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):349-53. PubMed ID: 25220739
[TBL] [Abstract][Full Text] [Related]
2. Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.
Furu K; Karlstad Ø; Zoega H; Martikainen JE; Bahmanyar S; Kieler H; Pottegård A
Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):373-379. PubMed ID: 27911044
[TBL] [Abstract][Full Text] [Related]
3. Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands.
van den Ban E; Souverein PC; Swaab H; van Engeland H; Egberts TC; Heerdink ER
Atten Defic Hyperact Disord; 2010 Dec; 2(4):213-20. PubMed ID: 21258431
[TBL] [Abstract][Full Text] [Related]
4. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
[TBL] [Abstract][Full Text] [Related]
5. Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006.
van den Ban E; Souverein P; Swaab H; van Engeland H; Heerdink R; Egberts T
J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):55-61. PubMed ID: 20166797
[TBL] [Abstract][Full Text] [Related]
6. A nationwide study of attention-deficit/hyperactivity disorder drug use among adults in Iceland 2003-2012.
Geirs DP; Pottegård A; Halldórsson M; Zoëga H
Basic Clin Pharmacol Toxicol; 2014 Nov; 115(5):417-22. PubMed ID: 24690162
[TBL] [Abstract][Full Text] [Related]
7. Exploratory analysis of early treatment discontinuation and clinical outcomes of patients with attention-deficit/hyperactivity disorder.
Wu SH; Wang K; Chen Y; Wang WQ; Wang F; Montgomery W; Treuer T
Asia Pac Psychiatry; 2017 Mar; 9(1):. PubMed ID: 26663807
[TBL] [Abstract][Full Text] [Related]
8. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.
Pottegård A; Bjerregaard BK; Glintborg D; Kortegaard LS; Hallas J; Moreno SI
Eur J Clin Pharmacol; 2013 Mar; 69(3):589-98. PubMed ID: 22811260
[TBL] [Abstract][Full Text] [Related]
9. Prescriptions for ADHD medication, 2004-08.
Lillemoen PK; Kjosavik SR; Hunskår S; Ruths S
Tidsskr Nor Laegeforen; 2012 Sep; 132(16):1856-60. PubMed ID: 22986969
[TBL] [Abstract][Full Text] [Related]
10. Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.
Dalsgaard S; Nielsen HS; Simonsen M
J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):432-9. PubMed ID: 24015896
[TBL] [Abstract][Full Text] [Related]
11. Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries.
Karlstad Ø; Zoëga H; Furu K; Bahmanyar S; Martikainen JE; Kieler H; Pottegård A
Eur J Clin Pharmacol; 2016 Dec; 72(12):1507-1514. PubMed ID: 27586399
[TBL] [Abstract][Full Text] [Related]
12. Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective.
Štuhec M; Locatelli I; Švab V
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):254-9. PubMed ID: 25803789
[TBL] [Abstract][Full Text] [Related]
13. Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood.
Brinker A; Mosholder A; Schech SD; Burgess M; Avigan M
J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):328-33. PubMed ID: 17630866
[TBL] [Abstract][Full Text] [Related]
14. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
[TBL] [Abstract][Full Text] [Related]
15. Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006-2009.
Zetterqvist J; Asherson P; Halldner L; Långström N; Larsson H
Acta Psychiatr Scand; 2013 Jul; 128(1):70-7. PubMed ID: 22943458
[TBL] [Abstract][Full Text] [Related]
16. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
17. Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.
Setyawan J; Guérin A; Hodgkins P; Gauthier G; Cloutier M; Wu E; Erder MH
J Med Econ; 2013 Nov; 16(11):1275-89. PubMed ID: 24004347
[TBL] [Abstract][Full Text] [Related]
18. [Use of methylphenidate among children in Iceland 1989-2006].
Zoëga H; Baldursson G; Halldórsson M
Laeknabladid; 2007 Dec; 93(12):825-32. PubMed ID: 18057472
[TBL] [Abstract][Full Text] [Related]
19. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany.
Lindemann C; Langner I; Kraut AA; Banaschewski T; Schad-Hansjosten T; Petermann U; Petermann F; Schreyer-Mehlhop I; Garbe E; Mikolajczyk RT
J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):307-14. PubMed ID: 22856384
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study.
Fredriksen M; Peleikis DE
Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):23-31. PubMed ID: 26404187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
